Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1987 Oct;24(4):473–477. doi: 10.1111/j.1365-2125.1987.tb03200.x

The trans-hepatic extraction of nifedipine.

V F Challenor 1, D G Waller 1, A G Renwick 1, B S Gruchy 1, C F George 1
PMCID: PMC1386309  PMID: 3689628

Abstract

1. The trans-hepatic extraction of nifedipine during steady state infusion was studied in six patients undergoing cardiac catheterisation for suspected coronary disease. 2. Mean extraction ratio across the liver was 0.64 but hepatic clearance accounted for a mean of only 65% of total body clearance. 3. These results are consistent with the liver as the major site of metabolism of nifedipine, but also suggest that significant metabolism occurs outside the liver.

Full text

PDF
473

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bärnhielm C., Hansson G. Oxidation of 1,4-dihydropyridines by prostaglandin synthase and the peroxidic function of cytochrome P-450. Demonstration of a free radical intermediate. Biochem Pharmacol. 1986 May 1;35(9):1419–1425. doi: 10.1016/0006-2952(86)90105-x. [DOI] [PubMed] [Google Scholar]
  2. Bärnhielm C., Skånberg I., Borg K. O. Cytochrome P-450-dependent oxidation of felodipine--a 1,4-dihydropyridine--to the corresponding pyridine. Xenobiotica. 1984 Sep;14(9):719–726. doi: 10.3109/00498258409151470. [DOI] [PubMed] [Google Scholar]
  3. Feely J. Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects. Br J Clin Pharmacol. 1984 Jan;17(1):83–85. doi: 10.1111/j.1365-2125.1984.tb05003.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Foster T. S., Hamann S. R., Richards V. R., Bryant P. J., Graves D. A., McAllister R. G. Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects. J Clin Pharmacol. 1983 Apr;23(4):161–170. doi: 10.1002/j.1552-4604.1983.tb02720.x. [DOI] [PubMed] [Google Scholar]
  5. Grainger S. L., Keeling P. W., Brown I. M., Marigold J. H., Thompson R. P. Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man. Clin Sci (Lond) 1983 Feb;64(2):207–212. doi: 10.1042/cs0640207. [DOI] [PubMed] [Google Scholar]
  6. Kleinbloesem C. H., van Brummelen P., Faber H., Danhof M., Vermeulen N. P., Breimer D. D. Variability in nifedipine pharmacokinetics and dynamics: a new oxidation polymorphism in man. Biochem Pharmacol. 1984 Nov 15;33(22):3721–3724. doi: 10.1016/0006-2952(84)90165-5. [DOI] [PubMed] [Google Scholar]
  7. Stern Z., Zylber-Katz E., Levy M. Nifedipine plasma concentration in patients treated for angina pectoris. Int J Clin Pharmacol Ther Toxicol. 1984 Apr;22(4):198–203. [PubMed] [Google Scholar]
  8. Waller D. G., Renwick A. G., Gruchy B. S., George C. F. The first pass metabolism of nifedipine in man. Br J Clin Pharmacol. 1984 Dec;18(6):951–954. doi: 10.1111/j.1365-2125.1984.tb02569.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES